| 1 | 1639-01-6 | 2,3-DIMETHYL-2-BUTANETHIOL | C6H14S | 118.24 | -113.76°C (estimate) | |
| 2 | 1639-03-8 | 3-methylpentane-3-thiol | C6H14S | 118.24 | | |
| 3 | 1639-04-9 | 2-Methyl-3-pentanethiol | C6H14S | 118.24 | | |
| 4 | 1639-05-0 | 2-Pentanethiol, 4-methyl- | C6H14S | 118.24 | -113.76°C (estimate) | |
| 5 | 1639-06-1 | 4-heptanethiol | C7H16S | 132.27 | | |
| 6 | 1639-09-4 | 1-Heptanethiol | C7H16S | 132.27 | -43°C | |
| 7 | 1639-31-2 | 3,4,5-TRIMETHYLANILINE | C9H13N | 135.21 | 79-80℃ | |
| 8 | 1639-35-6 | 1-Propanone,3-(dimethylamino)-1-(2-hydroxyphenyl)-, hydrochloride (1:1) | C11H16ClNO2 | 229.70324 | | |
| 9 | 1639-37-8 | ethyl alpha-oxofuran-2-acetate | C8H8O4 | 168.15 | 27-29 °C | |
| 10 | 1639-39-0 | 2,4-Diamino-6-(p-tolyloxy)-1,3,5-triazine | | | | |
| 11 | 1639-43-6 | ANDROSTENEDIOL-3-ACETATE | C21H32O3 | 332.48 | 147-148° | |
| 12 | 1639-60-7 | PROPOXYPHENE HYDROCHLORIDE | C22H29NO2.ClH | 375.93 | 165-1670C | 3.7mg/L(25 ºC) |
| 13 | 1639-66-3 | SULFONATED ALIPHATIC POLYESTER | C52H111Na3O7S | 446.57 | | |
| 14 | 1639-77-2 | Iron(II) chloride dihydrate | Cl2FeH4O2 | | | |
| 15 | 1639-79-8 | Barverine | C29H43N5O3 | 509.68 | 97-98 °C(Solv: isopropanol (67-63-0)) | |
| 16 | 16390-07-1 | 4-chloro-1'-(4-methoxyphenyl)benzohydrazide | C14H13ClN2O2 | 276.72 | | |
| 17 | 16390-61-7 | 1-Phenyl-o-carborane | C8H5B10 | 209.23 | | |
| 18 | 16390-62-8 | 1,2-Dicarbadodecaborane(12), 3-phenyl- | C8H5B10 | 209.23 | | |
| 19 | 1639006-04-4 | 1,2-cyclohexanedione 1-({4-nitrophenyl}hydrazone) | C12H13N3O3 | 247.24992 | | |
| 20 | 1639009-81-6 | CD532 | C26H25F3N8O | 522.52 | | |
| 21 | 1639011-56-5 | 1H-Pyrrole-2-carboxylic acid, 3-bromo-1-methyl- | C6H6BrNO2 | 204.02 | | |
| 22 | 1639014-61-1 | Benzeneethanamine, 4-chloro-, hydriodide (1:1) | C8H11ClIN | 283.54 | | |
| 23 | 1639014-61-2 | 4-Chlorophenylethylammonium Iodide | | | | |
| 24 | 1639014-72-4 | 2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-(difluoromethoxy)-6-quinazolinyl]-4-(dimethylamino)-, (2E)- | C21H19ClF3N5O2 | 465.86 | | |
| 25 | 1639014-74-6 | 1639014-74-6 | | | | |
| 26 | 1639024-15-9 | Karavilagenin F | C31H50O5 | 502.74 | | |
| 27 | 1639040-81-5 | EGFR IN 542 | C23H18FN5 | 383.43 | | |
| 28 | 1639040-94-0 | 2-Propenamide, N-[4-[(3-bromo-1H-indol-5-yl)amino]-6-quinazolinyl]- | C19H14BrN5O | 408.25 | | |
| 29 | 1639040-95-1 | Propanamide, N-[4-[(3-bromo-1H-indol-5-yl)amino]-6-quinazolinyl]-3-chloro- | C19H15BrClN5O | 444.71 | | |
| 30 | 1639042-08-2 | AZD9496 | C25H25F3N2O2 | 442.47 | | |
| 31 | 1639042-28-6 | AZD9496 (maleate) | C29H29F3N2O6 | 558.55 | | |
| 32 | 1639042-36-6 | (R)-N-(1-(1H-indol-3-yl)propan-2-yl)-2-fluoro-2-methylpropan-1-amine | C15H21FN2 | 248.3390432 | | |
| 33 | 1639042-39-9 | (E)-methyl 3-(3,5-difluoro-4-formylphenyl)acrylate | C11H8F2O3 | 226.18 | | |
| 34 | 1639042-83-3 | 2-fluoro-2-methylpropane-1,3-diol | C4H9FO2 | 108.11 | | |
| 35 | 1639043-81-4 | QUINAZOLINAMINE, 8-METHOXY-7-(1-METHYL-1H-PYRAZOL-4-YL)-N-[4-[3-
(4-MORPHOLINYL)-1H-1,2,4-TRIAZOL-1-YL]PHENYL]- | C24H23ClN8O2 | 490.94 | | |
| 36 | 1639049-53-8 | tert-butyl (4-iodo-6-morpholinopyridin-3-yl)carbamate | | | | |
| 37 | 1639050-37-5 | trans-13'-Hydroxy-delta-tocotrienol | C27H40O3 | 412.6 | | |
| 38 | 1639050-53-5 | (2E)-2-(2,4-dioxo-1,3-thiazolidin-5-ylidene)acetic acid | C5H3NO4S | 173.15 | | |
| 39 | 1639050-72-8 | 6-bromo-3-iodo-1-isopropyl-1H-pyrazolo[4,3-c]pyridine | C9H9BrIN3 | 366 | | |
| 40 | 1639063-72-1 | Benzenemethanol, 4-(4,5-dihydro-4,4-dimethyl-2-oxazolyl)-α-[4-(4,5-dihydro-4,4-dimethyl-2-oxazolyl)phenyl]-α-methyl- | C24H28N2O3 | 392.49 | | |
| 41 | 16391-06-3 | DIMETHYLPHOSPHINIC ACID | C2H7O2P | 94.05 | | |
| 42 | 16391-07-4 | ETHYL METHYLPHOSPHINATE | C3H9O2P | 108.08 | | |
| 43 | 16391-62-1 | 7,12-diphenylbenzo[k]fluoranthene | C32H20 | 404.5 | 250 °C | |
| 44 | 16391-75-6 | diethanolamine fusidate | C35H59NO8 | 621.84486 | 96 - 100°C | |
| 45 | 16391-79-0 | 2-Pyridinecarboxaldehyde,2-(5-nitro-2-pyridinyl)hydrazone | C11H9N5O2 | 243.22146 | | |
| 46 | 1639111-11-7 | tert-Butyl 8-methyl-3,8-diazabicyclo[3.2.1]octane-3-carboxylate | C12H22N2O2 | 226.31528 | | |
| 47 | 1639113-91-9 | 3-MethoxyMethyl-3-hydroxyMethyloxetane | C6H12O3 | 132.16 | | |
| 48 | 1639114-38-7 | 3-Fluoro-1-methyl-5-nitro-1H-pyridin-2-one | C6H5FN2O3 | 172.11 | | |
| 49 | 1639114-39-8 | 5-Amino-3-fluoro-1-methyl-1H-pyridin-2-one | C6H7FN2O | 142.13 | | |
| 50 | 1639114-45-6 | ethyl 1-cyclopropyl-5-methyl-1H-pyrazole-3-carboxylate | C10H14N2O2 | 194.23 | | |
| 51 | 1639114-94-5 | ethyl 1-cyclopropyl-1H-pyrazole-5-carboxylate | C9H12N2O2 | 180.2 | | |
| 52 | 1639115-02-8 | ethyl 4-iodo-1-isopropyl-1H-pyrazole-5-carboxylate | C9H13IN2O2 | 308.12 | | |
| 53 | 1639115-07-3 | 1H-Pyrazole-3-carboxylic acid, 1-cyclopropyl-, ethyl ester | C9H12N2O2 | 180.2 | | |
| 54 | 1639115-24-4 | ethyl 4-iodo-1-isopropyl-1H-pyrazole-3-carboxylate | C9H13IN2O2 | 308.12 | | |
| 55 | 1639115-52-8 | Pyrrolo[3,4-c]pyrazol-6(1H)-one, 4-(4-chlorophenyl)-1-cyclopropyl-5-(1,6-dihydro-1,5-dimethyl-6-oxo-3-pyridinyl)-4,5-dihydro-3-methyl-, (4R)- | C22H21ClN4O2 | 408.88 | | |
| 56 | 1639115-99-3 | 3,8-dimethyl-6-nitro-[1,2,4]triazolo[4,3-a]pyridine | C8H8N4O2 | 192.17472 | | |
| 57 | 1639116-32-7 | 6-bromo-1,4-dimethyl-1H-benzo[d][1,2,3]triazole | C8H8BrN3 | 226.07 | | |
| 58 | 1639116-33-8 | Benzenamine, 5-bromo-N,3-dimethyl-2-nitro- | C8H9BrN2O2 | 245.07 | | |
| 59 | 1639116-68-9 | 5-CHLORO-3,7-DIMETHYL-3H-[1,2,3]TRIAZOLO[4,5-B]PYRIDINE(WXC07598) | C7H7ClN4 | 182.61 | | |
| 60 | 1639116-75-8 | TERT-BUTYL (6-CHLORO-3-METHYL-[1,2,4]TRIAZOLO[4,3-B]PYRIDAZIN-8-YL)CARBAMATE | C11H14ClN5O2 | 283.71 | | |
| 61 | 1639126-99-0 | rel-(4R,7R,8S)-1,4,5,8-Tetrahydro-8-[(methyl amino)methyl]-5-(sulfooxy)-6H-4,7-methanop yrazolo[3,4-e][1,3]diazepin-6-one | C9H13N5O5S | 303.29 | | |
| 62 | 163913-87-9 | Myelin Oligodendrocyte Glycoprotein Peptide Fragment 35-55 Rat, Mouse | C118H177N35O29S | | | |
| 63 | 1639134-02-3 | 4,4',4'',4'''-([2,2'-Bi(1,3-dithiolylidene)]-4,4',5,5'-tetrayl)tetrabenzaldehyde | C34H20O4S4 | 620.78 | | |
| 64 | 1639137-80-6 | Axitinib Impurity 27 | C24H20N4O2S | 428.51 | 214 - 215°C | |
| 65 | 1639138-00-3 | Benzamide, 2-[(1-acetyl-3-iodo-1H-indazol-6-yl)thio]-N-methyl- | C17H14IN3O2S | 451.28 | | |
| 66 | 1639139-65-3 | L-Lysinamide, N-[32-[4-[[[[4-[(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)methyl]cyclohexyl]carbonyl]amino]methyl]-1H-1,2,3-triazol-1-yl]-1,5-dioxo-3,9,12,15,18,21,24,27,30-nonaoxa-6-azadotriacont-1-yl]-L-phenylalanyl-N-[4-[[[[[2-[[[[(4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-14-oxo-1H-pyrano[3',4':... | C87H116N14O24 | 1741.93 | | |
| 67 | 163914-13-4 | 5-bromo-4-(bromomethyl)-2-methoxypyridine | C7H7Br2NO | 280.94 | | |
| 68 | 163914-97-4 | 1H-3-Benzazepin-2-aMine, 4,5-dihydro- | C10H12N2 | 160.22 | | |
| 69 | 163915-96-6 | 2-Nitrobenzyl methanesulfonate | C8H9NO5S | 231.23 | | |
| 70 | 1639151-95-3 | (E)-3-(2-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroisoquinolin-8-yl)acrylic acid | C17H21NO4 | 303.35 | | |
| 71 | 1639158-83-0 | Methyl 4-bromo-5-formyl-1H-pyrrole-2-carboxylate | C7H6BrNO3 | 232.03 | | |
| 72 | 1639159-47-9 | 1H-Indole-3-butanoic acid, β-[[(3α,5β)-3-hydroxy-24-oxocholan-24-yl]amino]-, (βS)- | C36H52N2O4 | 576.82 | | |
| 73 | 163916-55-0 | Carbamic acid, 5-(2,2-dimethyl-1,3-dioxolan-4-yl)-4-(phenylmethoxy)-1-(phenylmethyl)-3-pyrrolidinyl-, 1,1-dimethylethyl ester, 3S-3.alpha.,4.beta.,5.beta.(R*)- | C28H38N2O5 | 482.61 | | |
| 74 | 163916-56-1 | Acetamide, N-5-1,2-bis(acetyloxy)ethyl-4-(phenylmethoxy)-1-(phenylmethyl)-3-pyrrolidinyl-, 3S-3.alpha.,4.beta.,5.beta.(R*)- | C26H32N2O6 | 468.55 | | |
| 75 | 163918-99-8 | Benzonitrile, 4-(tetrahydro-2-oxo-1(2H)-pyrimidinyl)- | C11H11N3O | 201.22 | | |
| 76 | 163919-12-8 | 3-AMINO-3-FURAN-3-YL-PROPIONIC ACID ETHYL ESTER | C9H13NO3 | 183.2 | | |
| 77 | 163919-20-8 | 2-Pyridinesulfonamide,3-(hydroxyamino)-(9CI) | C5H7N3O3S | 189.19 | | |
| 78 | 1639198-67-6 | N3-L-Orn(Boc)-OH·CHA | C10H18N4O4 | 258.27432 | | |
| 79 | 16392-60-2 | 3α,5α-Tetrahydronorethisterone | C20H30O2 | 302.45 | | |
| 80 | 16392-68-0 | 2-(4,5-DIMETHOXY-2-NITROPHENYL)ACETOHYDRAZIDE | C10H13N3O5 | 255.23 | 184-185 °C | |
| 81 | 16392-77-1 | 2-(4-Chlorobenzyl)-1H-indene | C16H13Cl | 240.73 | | |
| 82 | 1639204-71-9 | Benzene, 1-chloro-4-fluoro-2-iodo-5-methyl- | C7H5ClFI | 270.47 | | |
| 83 | 1639205-98-3 | 1H-Isoindole-1,3(2H)-dione, 2-[7-fluoro-3,4-dihydro-3-oxo-4-(2-propyn-1-yl)-2H-1,4-benzoxazin-6-yl]-3a,4,7,7a-tetrahydro- | C19H15FN2O4 | 354.33 | | |
| 84 | 1639207-37-6 | rac 1-Oleoyl-2-chloropropanediol | C21H39ClO3 | 374.99 | | |
| 85 | 1639207-38-7 | rac-1-Linoleoyl-2-chloropropanediol | C21H37ClO3 | 372.97 | | |
| 86 | 1639207-40-1 | rac-1-Linoleoyl-3-oleoyl-2-chloropropanediol | C39H69ClO4 | 637.42 | | |
| 87 | 1639207-41-2 | rac-1-Palmitoyl-3-oleoyl-2-chloropropanediol | C37H69ClO4 | 613.39 | | |
| 88 | 1639207-42-3 | (Z)-2-Chloropropane-1,3-diyl Dioleate | C39H71ClO4 | 639.43 | | |
| 89 | 1639207-43-4 | 9,12-Octadecadienoic acid (9Z,12Z)-, 2-chloro-3-[(1-oxooctadecyl)oxy]propyl ester | C39H71ClO4 | 639.43 | | |
| 90 | 1639207-44-5 | Octadecanoic acid, 2-chloro-3-[(1-oxohexadecyl)oxy]propyl ester | C37H71ClO4 | 615.41 | | |
| 91 | 1639207-45-6 | 9-Octadecenoic acid (9Z)-, 2-chloro-3-[(1-oxooctadecyl)oxy]propyl ester | C39H73ClO4 | 641.45 | | |
| 92 | 1639207-59-2 | 3,3,4,4,5,5-hexafluoropentan-1-ol | C5H6F6O | 196.09 | | |
| 93 | 1639208-51-7 | (2R,3R,11bR)-3-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-yl L-valinate dihydrochloride | C24H40Cl2N2O4 | 491.4914 | | |
| 94 | 1639208-54-0 | Valbenazine tosylate | C31H46N2O7S | 590.78 | | |
| 95 | 1639209-60-1 | (5Z)-5-[(4-tert-butylphenyl)methylidene]-1,3-thiazolidine-2,4-dione | C14H15NO2S | 261.34 | | |
| 96 | 163921-61-7 | Fluconazole Impurity | C13H10F2N6 | 288.26 | | |
| 97 | 163921-62-8 | Fluconazole | C13H10F2N6 | 288.26 | | |
| 98 | 163921-65-1 | Azithromycin-d3 | C38H72N2O12 | 748.98448 | 125-1290C | |
| 99 | 163921-85-5 | PERFLUOROOCTYLETHYL TRISILOXANE | C17H25F17O2Si3 | 668.61 | | |
| 100 | 1639210-25-5 | Tricyclo[3.3.1.13,7]decan-1-amine, 3-(2-fluoroethyl)-, hydrochloride (1:1) | C12H21ClFN | 233.76 | | |
| 101 | 1639210-26-6 | Tricyclo[3.3.1.13,7]decan-1-amine, 3-(2-fluoroethyl)- | C12H20FN | 197.29 | | |
| 102 | 1639210-89-1 | 5-Bromo-3,4-dimethylthieno[2,3-c]pyridazine-6-carbonitrile | C9H6BrN3S | 268.13 | | |
| 103 | 1639211-37-2 | COF-JLU-2 | C9H10N2O6 | 242.19 | | |
| 104 | 1639212-96-6 | Triphenylsulfonium, α,α,β,β-tetrafluorohexahydrospiro[4,7-methano-1,3-benzodioxole-2,2'-tricyclo[3.3.1.13,7]decane]-5-ethanesulfonic acid (1:1) | C37H38F4O5S2 | 702.82 | | |
| 105 | 1639216-79-7 | tert-butyl N-[cis-2-(hydroxymethyl)cyclobutyl]carbamate | C10H19NO3 | 201.26276 | | |
| 106 | 1639217-01-8 | tris[(1,1-dimethyl)ethyl] 10-[2-(didodecylamino)-2-oxoethyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetate | | | | |
| 107 | 1639217-02-9 | 10-[2-(Didodecylamino)-2-oxoethyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triaceti… | | | | |
| 108 | 1639220-15-7 | Sigma-1 receptor antagonist 2 | C20H26ClN3O2 | 375.89 | | |
| 109 | 1639220-17-9 | Sigma-1 receptor antagonist 3 | C19H23ClFN3O | 363.86 | | |
| 110 | 1639220-19-1 | Sigma-1 receptor antagonist 1 | C19H23Cl2N3O | 380.31 | | |
| 111 | 163923-18-0 | N-Benzyl-6-(4-Phenylbutoxy)Hexan-1-Amine Hydrochloride | C23H34ClNO | 375.98 | 142-145oC | |
| 112 | 163923-19-1 | 2-Hydroxy-5-[[[6,6-(4-phenylbutoxy)hexylbenzyl]amino]acetyl]benzaldehyde | C32H40NO4 | 501.66 | | |
| 113 | 163923-52-2 | (2H-1,3-benzodioxol-5-ylmethyl)[3-(1H-imidazol-1-yl)propyl]amine | C14H17N3O2 | 259.3 | | |
| 114 | 1639257-36-5 | 8(17),12E,14-Labdatrien-20-oic acid | C20H30O2 | 302.45 | | |
| 115 | 1639257-37-6 | 12E,14-Labdadien-20,8β-olide | C20H30O2 | 302.45 | | |
| 116 | 1639257-39-8 | Halopemide Impurity 54 | | | | |
| 117 | 1639257-41-2 | Halopemide Impurity 81 | | | | |
| 118 | 1639257-46-7 | Halopemide Impurity 56 | | | | |
| 119 | 1639257-47-8 | Halopemide Impurity 94 | | | | |
| 120 | 1639257-50-3 | Halopemide Impurity 88 | | | | |
| 121 | 1639263-28-7 | 1H-Imidazole-4-carboxylic acid, 1-(4-bromophenyl)-2-[1-(2-chlorophenyl)-1-methylethyl]-, ethyl ester | C21H20BrClN2O2 | 447.75 | | |
| 122 | 1639263-80-1 | Vortioxetine Impurity 25 | C18H22N2O2S | 330.44 | | |
| 123 | 1639263-83-4 | Benzene, 1-[(2-chlorophenyl)thio]-2,4-dimethyl- | C14H13ClS | 248.77 | | |
| 124 | 1639264-46-2 | Cemdisiran | | | | |
| 125 | 1639265-43-2 | 1H-Indole-7-carbonitrile, 1-[3-(benzoyloxy)propyl]-5-(2-nitropropyl)- | C22H21N3O4 | 391.42 | | |
| 126 | 1639265-44-3 | 1H-Indole-7-carbonitrile, 5-(2-aminopropyl)-1-[3-(benzoyloxy)propyl]- | C22H23N3O2 | 361.44 | | |
| 127 | 1639265-45-4 | 1H-Indole-7-carbonitrile, 5-[(2R)-2-aminopropyl]-1-[3-(benzoyloxy)propyl]- | C22H23N3O2 | 361.44 | | |
| 128 | 1639265-59-0 | 1639265-59-0 | C32H32F3N3O4 | 579.61 | | |
| 129 | 163927-29-5 | (R)-(-)-4-(3-Isothiocyanatopyrrolidin-1-yl)-7-Nitro-2,1,3-Benzoxadiazole | C11H9N5O3S | 291.29 | | |
| 130 | 163927-30-8 | (S)-(+)-4-(3-Isothiocyanatopyrrolidin-1-yl)-7-Nitro-2,1,3-Benzoxadiazole | C11H9N5O3S | 291.29 | | |
| 131 | 163927-31-9 | (R)-(-)-4-(N,N-Dimethylaminosulfonyl)-7-(3-Isothiocyanatopyrrolidin-1-yl)-2,1,3-Benzoxadiazole | C13H15N5O3S2 | 353.42 | | |
| 132 | 163927-32-0 | (S)-(+)-4-(N,N-Dimethylaminosulfonyl)-7-(3-Isothiocyanatopyrrolidin-1-yl)-2,1,3-Benzoxadiazole | C13H15N5O3S2 | 353.42 | | |
| 133 | 163928-56-1 | Pyridine, 3-bromo-, radical ion(1-) (9CI) | C5H4BrN | 158 | | |
| 134 | 1639289-05-6 | ethyl 2-bromo-1-methyl-1H-imidazole-4-carboxylate | C7H9BrN2O2 | 233.06 | | |
| 135 | 163929-77-9 | (R)-tert-butyl 2,5-dioxopyrrolidin-3-ylcarbamate | C9H14N2O4 | 214.21846 | | |
| 136 | 1639298-80-8 | 4-Pyridinamine, 2-chloro-6-(4-chlorophenoxy)- | C11H8Cl2N2O | 255.1 | | |
| 137 | 1639298-89-7 | 4-Chloro-2-fluoro-5-nitro-benzaldehyde | C7H3ClFNO3 | 203.55 | | |
| 138 | 16393-03-6 | 1,3-Benzoxazepine-2-carbonitrile | C10H6N2O | 170.17 | | |
| 139 | 16393-49-0 | azanium hydroxide | H5NO | | | |
| 140 | 16393-88-7 | Stannane, trimethyl(trimethylsilyl)- | C6H18SiSn | 237 | | |
| 141 | 16393-89-8 | Germane, trimethyl(trimethylstannyl)- | C6H18GeSn | 281.56 | | |
| 142 | 163930-30-1 | 1-((4-(2-iodoethyl)phenoxy)methyl)benzene | C15H15IO | 338.18 | | |
| 143 | 1639303-73-3 | L-Lysine, N6-(L-prolyl-L-alanyl-L-lysyl)-N2-[[(3S)-1,2,3,4-tetrahydro-6,7-dihydroxy-1,1-dimethyl-3-isoquinolinyl]carbonyl]- | C32H51N7O8 | 661.79 | | |
| 144 | 163931-61-1 | Tetrabutylammonium triphenyldifluorosilicate (TBAT) | C34H51F2NSi | 539.86 | 157-163°C(lit.) | |
| 145 | 1639324-58-5 | Inclisiran sodium | | | | |
| 146 | 1639325-43-1 | ALN-AS1 | | | | |
| 147 | 1639325-44-2 | Givosiran sodium | | | | |
| 148 | 163934-41-6 | Formamide, N,N'-(oxydi-4,1-phenylene)bis- | C14H12N2O3 | 256.26 | | |
| 149 | 1639342-81-6 | (8α,9S)-9-isothiocyanato-Cinchonan | C20H21N3S | 335.47 | | |
| 150 | 1639345-42-8 | 4-[fluoro(dimethyl)silyl]butanenitrile | C6H12FNSi | 145.25 | | |
| 151 | 1639346-19-2 | 4H-Benzo[def]carbazole, 2-bromo- | C14H8BrN | 270.12 | | |
| 152 | 1639350-46-1 | 1-(oxan-4-yl)-1H-pyrazol-4-amine hydrochloride | | | | |
| 153 | 1639351-92-0 | Mc-Val-Cit-PAB-Cl | C28H39ClN6O6 | 591.1 | | |
| 154 | 1639352-03-6 | MC-VC-PABC-DNA31 | C77H96N10O21 | 1497.64 | | |
| 155 | 1639352-06-9 | MC-Val-Cit-PAB-dimethylDNA31 | C78H101N10O19+ | 1482.72 | | |
| 156 | 1639355-28-4 | (2R,6S)-2,6-dimethylpiperidine-1-carbonyl chloride | C8H14ClNO | 175.66 | | |
| 157 | 1639357-93-9 | 5H-Benzothiazolo[3,2-a][1,8]naphthyridine-6-carboxamide, 2-[(3aR,6aS)-hexahydro-5-methylpyrrolo[3,4-c]pyrrol-2(1H)-yl]-N-[(5-methyl-2-pyrazinyl)methyl]-5-oxo-, rel- | C28H27N7O2S | 525.62 | | |
| 158 | 1639358-50-1 | CBB3001 | C19H27NO5 | 349.42 | | |
| 159 | 163936-30-9 | Benzoic acid, 2,4,5-trimethoxy-, ethyl ester | C12H16O5 | 240.25 | | |
| 160 | 163936-78-5 | 2H-1,2,4-Benzothiadiazine, 7-chloro-3,4-dihydro-3-methyl-, 1,1-dioxide, (+)- | C8H9ClN2O2S | 232.68 | | |
| 161 | 163936-79-6 | 2H-1,2,4-Benzothiadiazine, 7-chloro-3,4-dihydro-3-methyl-, 1,1-dioxide, (-)- | C8H9ClN2O2S | 232.68 | | |
| 162 | 163936-88-7 | 2-Propanone, 1-(nitroamino)- (9CI) | C3H6N2O3 | 118.09 | | |
| 163 | 1639370-02-7 | 3-Trifluoromethylsulfanyl-thiophene-2-carboxylic acid methyl ester | C7H5F3O2S2 | 242.24 | | |
| 164 | 1639371-28-0 | 1-Ethoxy-4-[(trifluoromethyl)thio]benzene | C9H9F3OS | 222.23 | | |
| 165 | 1639372-81-8 | 1-Pyrrolidinecarboxylic acid, 3-hydroxy-4-phenyl-, 1,1-dimethylethyl ester, (3R,4R)-rel- | C15H21NO3 | 263.33 | | |
| 166 | 1639373-19-5 | 2,5-dichloro-4,6-dimethylpyridin-3-amine | C7H8Cl2N2 | 191.06 | | |
| 167 | 1639373-35-5 | 3,6-dichloro-2,4-dimethylpyridine | C7H7Cl2N | 176.04 | | |
| 168 | 1639373-36-6 | 2,3-Dichloro-4,6-dimethylpyridine | C7H7Cl2N | 176.04 | | |
| 169 | 16394-40-4 | N-(4-BroMo-2-hydroxy-phenyl)-acetaMide | C8H8BrNO2 | 230.06 | | |
| 170 | 16394-44-8 | 2,2'-[cyclohexane-1,4-diylbis(oxy)]bisethanol | C10H20O4 | 204.26 | | |
| 171 | 16394-67-5 | 2β,3β-Epoxy-3-methyl-5α-androstan-17β-ol | C20H32O2 | 304.47 | | |
| 172 | 16394-70-0 | 21-Acetyloxy-9-fluoro-11-(trifluoroace-tyloxy)-17-hydroxy-16-methylpregna-1,4-diene-3,20-dione | C26H30F4O7 | 530.51 | | |
| 173 | 16394-71-1 | 16-ALPHA-METHYLPREGNENOLONE | C22H34O2 | 330.5 | | |
| 174 | 16394-98-2 | 2,3,5,6-Norbornanetetrol,exo,exo-(8CI) | C7H12O4 | 160.17 | 191-194 °C | |
| 175 | 1639405-29-0 | N,N''-Bis(2-aminoethyl)thiourea Dihydrochloride | C5H15ClN4S | 198.71 | 199-201°C | |
| 176 | 1639406-55-5 | 2-amino-5-fluoro-1,3-Benzenediol | C6H6FNO2 | 143.12 | | |
| 177 | 1639406-69-1 | Piperidinium, 1-methyl-1-propyl-, hydroxide (1:1) | C9H21NO | 159.27 | | |
| 178 | 1639407-43-4 | TCNH10 | C49H30O | 634.76 | | |
| 179 | 1639407-50-3 | Spiro[7H-benzo[c]fluorene-7,9'-[9H]xanthene] | C29H18O | 382.45 | | |
| 180 | 1639407-54-7 | Spiro[7H-benzo[c]fluorene-7,9'-[9H]xanthene], 5-bromo- | C29H17BrO | 461.35 | | |
| 181 | 1639408-64-2 | Bis [2- (2,4-difluorophenyl) -5-trifluoromethylpyridine] [1,10-phenanthroline] iridium hexafluorophosphate | C36H18F16IrN4P | 1033.73 | | |
| 182 | 1639411-87-2 | 9-Azido-Neu5DAz | C14H22N6O8 | 402.3599 | | |
| 183 | 1639411-93-0 | (2R,4S,5R,6R)-2,4-Dihydroxy-5-(3-(3-methyl-3H-diazirin-3-yl)propanamido)-6-((1R,2R)-1,2,3-trihydroxypropyl)tetrahydro-2H-pyran-2-carboxylic acid | C14H23N3O9 | 377.35 | | |
| 184 | 1639412-34-2 | 10-(3,5-Dichloro-phenyl)-10H-phenoxazine | C18H11Cl2NO | 328.19 | | |
| 185 | 1639412-35-3 | 1-Naphthalenamine, N-[4-(2-dibenzofuranyl)phenyl]- | C28H19NO | 385.46 | | |
| 186 | 1639417-52-9 | 1639417-52-9 | | | | |
| 187 | 1639417-53-0 | Tenalisib | C23H18FN5O2 | 415.42 | | |
| 188 | 1639417-54-1 | Tenalisib R Enantiomer | C23H18FN5O2 | 415.42 | | |
| 189 | 1639417-55-2 | 1639417-55-2 | | | | |
| 190 | 1639419-51-4 | Cyclopenta[c]pyrrole-2(1H)-carboxamide, hexahydro-N-(3-methoxy-1,2,4-thiadiazol-5-yl)-5-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-, (3aα,5α,6aα)-, sulfate (1:1) | C18H24N8O6S2 | 512.56 | | |
| 191 | 1639420-13-5 | MRS 5980 | | | | |
| 192 | 1639422-97-1 | JH-VIII-157-02 | C28H27N5O2 | 465.55 | | |
| 193 | 1639424-37-5 | 1,3,5-Triazine, 2,4-diphenyl-6-(9,9'-spirobi[9H-fluoren]-3-yl)- | C40H25N3 | 547.65 | | |
| 194 | 1639425-16-3 | 2,7-Di-9H-carbazol-9-yl-9,10-dihydro-9,9-dimethyl-10-phenylacridine | C45H33N3 | 615.78 | | |
| 195 | 1639429-81-4 | MATFPFPXUXCLHI-UHFFFAOYSA-N | C20H18N2O | 302.37 | | |
| 196 | 1639430-82-2 | L-Ornithinamide, N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-L-valyl-N5-(aminocarbonyl)-N-[4-[(carboxyoxy)methyl]phenyl]-, 5′-ester with 2′-deoxy-2′,2′-difluorocytidine | C38H49F2N9O12 | 861.85 | | |
| 197 | 1639438-67-7 | MmpL3-IN-3 | C26H33ClN2Si | 437.09 | | |
| 198 | 1639444-93-1 | 4-bromo-3-methyl-1H-pyrrolo[2,3-c]pyridine | C8H7BrN2 | 211.06 | | |
| 199 | 1639447-03-2 | (11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide | | | | |
| 200 | 1639448-07-9 | (11aR)-1,10-Bis(3,5-di-tert-butylphenyl)-12-hydroxy-4,5,6,7-tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocine 12-oxide | C45H55O4P | 690.89 | | |
| 201 | 1639449-47-0 | 4,4'-(thiazolo[5,4-d]thiazole-2,5-diyl)bis(N,N-bis(4-bromophenyl)aniline) | C40H24Br4N4S2 | 944.4 | | |
| 202 | 1639449-49-2 | Benzenamine, 4,4'-thiazolo[5,4-d]thiazole-2,5-diylbis[N,N-bis[4-[5-[4-(diphenylamino)phenyl]-4-dodecyl-2-thienyl]phenyl]- | C176H184N8S6 | 2603.79 | | |
| 203 | 1639449-99-2 | DTBT-2Th48Br | C58H86Br2N2S5 | 1131.45 | | |
| 204 | 1639450-02-4 | 1,2,6-triazaspiro[2.5]oct-1-ene | C5H9N3 | 111.15 | | |
| 205 | 1639454-74-2 | trans-2-{[(tert-butoxy)carbonyl]amino}-1-fluorocyclobutane-1-carboxylic acid | C10H16FNO4 | 233.24 | | |
| 206 | 1639454-85-5 | (1S,2S)-2-{[(tert-butoxy)carbonyl]amino}-1-fluorocyclobutane-1-carboxylic acid | C10H16FNO4 | 233.2367432 | | |
| 207 | 1639457-19-4 | 5-Methoxy-1-Methyl-1H-pyrrolo[3,2-b]pyridine | C9H10N2O | 162.19 | | |
| 208 | 1639462-15-9 | Diflunisal Impurity 3 | C13H8F2O3 | 250.2 | | |
| 209 | 1639480-20-8 | Methyl 2-chloro-7-methoxy-5-benzoxazolecarboxylate | C10H8ClNO4 | 241.63 | | |
| 210 | 1639481-62-1 | 3-Morpholinone, 2,5,5-trimethyl-4-(phenylmethyl)- | C14H19NO2 | 233.31 | | |
| 211 | 1639481-63-2 | 3-Morpholinone, 2,5,5-trimethyl-4-(phenylmethyl)-2-(2-propen-1-yl)- | C17H23NO2 | 273.37 | | |
| 212 | 1639481-65-4 | 3-Morpholinone, 2-(2-hydroxyethyl)-2,5,5-trimethyl-4-(phenylmethyl)- | C16H23NO3 | 277.36 | | |
| 213 | 1639481-94-9 | 3-Morpholinone, 5-(hydroxymethyl)-2,2-dimethyl-4-(phenylmethyl)- | C14H19NO3 | 249.31 | | |
| 214 | 1639481-97-2 | 5-(Fluoromethyl)-2,2-dimethylmorpholine | C7H14FNO | 147.19 | | |
| 215 | 1639482-84-0 | 2-allyl-4-benzyl-2-methylmorpholin-3-one | C15H19NO2 | 245.32 | | |
| 216 | 1639482-86-2 | 3-Morpholinone, 2-(2-hydroxyethyl)-2-methyl-4-(phenylmethyl)- | C14H19NO3 | 249.31 | | |
| 217 | 1639483-72-9 | 1-Piperazinecarboxylic acid, 3-methyl-5-oxo-4-(phenylmethyl)-, 1,1-dimethylethyl ester | C17H24N2O3 | 304.38 | | |
| 218 | 1639484-18-6 | 3-Morpholinone, 5-(1-hydroxy-1-methylethyl)-2,2-dimethyl-4-(phenylmethyl)- | C16H23NO3 | 277.36 | | |
| 219 | 16395-11-2 | 3-(3,4-Dichlorophenyl)quinazoline-2,4(1H,3H)-dione | C14H8Cl2N2O2 | 307.13 | 282-283 °C(Solv: isopropanol (67-63-0); N,N-dimethylformamide (68-12-2)) | |
| 220 | 16395-57-6 | L-Pyroglutamamide | C5H8N2O2 | 128.13 | 148-150 °C(Solv: methanol (67-56-1)) | |
| 221 | 16395-58-7 | Ac-Pro-NH2 | C7H12N2O2 | 156.18 | 178-180 °C | |
| 222 | 16395-67-8 | 1-chloro-N,N-bis(chloromethyl)methanamine | C3H6Cl3N | 162.44544 | | |
| 223 | 16395-79-2 | 3-Ethylidene-4-methyl-2,5-pyrrolidinedione | C7H9NO2 | 139.15 | | |
| 224 | 16395-80-5 | N-Methyl-N-nitrosopropanamide | C4H8N2O2 | 116.12 | | |
| 225 | 16395-81-6 | N-methyl-N-nitroso-butanamide | C5H10N2O2 | 130.15 | | |
| 226 | 16395-82-7 | N-Methyl-N-nitrosohexanamide | C7H14N2O2 | 158.2 | | |
| 227 | 16395-83-8 | Heptanamide, N-methyl-N-nitroso- | C8H16N2O2 | 172.22 | | |
| 228 | 16395-84-9 | Decanamide, N-methyl-N-nitroso- | C11H22N2O2 | 214.3 | | |
| 229 | 16395-85-0 | Dodecanamide, N-methyl-N-nitroso- | C13H26N2O2 | 242.36 | | |
| 230 | 163955-47-3 | n-Octyl-α-D-thio-mannopyranosid | C14H28O5S | 308.43 | | |
| 231 | 163955-59-7 | 4-Keto 9-cis Retinoic Acid Methyl Ester | C21H28O3 | 328.2 | | |
| 232 | 163956-01-2 | Thiocolchicoside Tetraacetate | C35H41NO14S | 731.77 | >159°C (dec.) | |
| 233 | 163956-16-9 | Kaempferol-3-O-(6''-O-cis-coumaryl)glucoside | C30H26O13 | 594.52 | | |
| 234 | 163956-72-7 | 2-(4-(Methylsulfinyl)butyl)isoindoline-1,3-dione | C13H15NO3S | 265.33 | | |
| 235 | 163957-35-5 | (R)-2-AMINO-3-(3,4-DIMETHOXYPHENYL)PROPAN-1-OL | C11H17NO3 | 211.26 | | |
| 236 | 163957-95-7 | Lacosamide Impurity P | C11H14N2O3 | 222.24 | | |
| 237 | 163958-73-4 | TAPI-0 | C24H32N4O5 | 456.53 | | |
| 238 | 163959-12-4 | Cyclopentanol, 2-(1-fluoro-1-methylethyl)-5-methyl-, [1-alpha-,2-ba-(R*),5-ba-]- (9CI) | C9H17FO | 160.23 | | |
| 239 | 163959-79-3 | 1H-Benzimidazole-2-methanamine,alpha-methyl-,(R)-(9CI) | C9H11N3 | 161.2 | 188-190°C | |
| 240 | 16396-05-7 | Carbamic acid,(2-chloroethyl)-, isobutyl ester (8CI) | C7H14ClNO2 | 179.64456 | | |
| 241 | 16396-31-9 | MFCD03119356 | C14H14N2O2 | 242.27 | 145 °C(Solv: water (7732-18-5)) | |
| 242 | 16396-79-5 | 14β-Hydroxypregnane-3,12,15,20-tetrone | C21H28O5 | 360.44 | | |
| 243 | 163960-35-8 | 6-Hepten-2-one, 5,6-dimethyl-, (S)- (9CI) | C9H16O | 140.22 | | |
| 244 | 163961-32-8 | Fatty acids, (C=16~18) and (C=18)-unsatd., branched and linear, Bu esters | | | | |
| 245 | 163961-33-9 | Carboxylic acids, di-, C4-6, polymers with epoxidized soybean oil | | | | |
| 246 | 16397-00-5 | 19-Norpregna-1,3,5(10)-triene-17,21-diol,3-methoxy-, 21-(4-methylbenzenesulfonate), (17a)- (9CI) | C28H36O5S | 484.64744 | | |
| 247 | 16397-19-6 | DL-2-Amino-1-hexanol | C6H15NO | 117.19 | | |
| 248 | 16397-28-7 | Fenproporex | C12H16N2 | 188.27 | | |
| 249 | 16397-37-8 | Cyclohexanemethanamine, N-ethyl-1-phenyl-, hydrochloride (1:1) | C15H24ClN | 253.81 | | |
| 250 | 16397-70-9 | 4-NITRO BENZOIC ACID 2-ETHYL-HEXYL ESTER | C15H21NO4 | 279.33154 | | |
| 251 | 16397-74-3 | 2-ethylhexyl cyclohexanecarboxylate | C15H28O2 | 240.38 | | |
| 252 | 16397-75-4 | 2-ethylhexyl hexanoate | C14H28O2 | 228.37 | | |
| 253 | 16397-78-7 | 2-ethylhexyl cinnamate | C17H24O2 | 260.37 | | |
| 254 | 16397-79-8 | Acetic acid,2,2,2-trichloro-, 2-ethylhexyl ester | C10H17Cl3O2 | 275.59978 | | |
| 255 | 16397-91-4 | MANGANESEION | | | | |
| 256 | 163972-12-1 | EPOXYQUINONE G109 | C18H27NO4 | 321.41 | 107-108 °C | |
| 257 | 163973-98-6 | FSH RECEPTOR-BINDING INHIBITOR FRAGMENT (BI-10) | C42H67N13O19 | 1058.06 | | |
| 258 | 163975-05-1 | 1-Bromo-3-(2,2,2-trifluoroethyl)benzene | C8H6BrF3 | 239.04 | | |
| 259 | 163975-06-2 | Benzene, (5,5,5-trifluoro-2-penten-1-yl)- | C11H11F3 | 200.2 | | |
| 260 | 163977-51-3 | 3-(4-Methoxyphenyl)-3,6-dihydro-7H-[1,2,3]triazolo[4,5-d]pyrimidin-7-one | C11H9N5O2 | 243.22 | | |
| 261 | 163977-85-3 | 4H-1-Benzopyran-8-aceticacid,3-amino-4-oxo-2-phenyl-(9CI) | C17H13NO4 | 295.29 | | |
| 262 | 1639779-27-3 | 1H-Benzimidazole-7-carboxaldehyde, 6-chloro- | C8H5ClN2O | 180.59 | | |
| 263 | 163978-34-5 | 2-amino-4-(2-chlorophenyl)-6,7-dihydro-5H-cyclopenta[b]pyridine-3-carbonitrile | C15H12ClN3 | 269.73 | | |
| 264 | 163978-37-8 | 2-amino-4-(2-thienyl)-4a,5,6,7-tetrahydro-1,3,3(4H)-naphthalenetricarbonitrile | C17H14N4S | 306.38 | | |
| 265 | 163978-39-0 | 2-amino-4-(4-methylphenyl)-4a,5,6,7-tetrahydro-1,3,3(4H)-naphthalenetricarbonitrile | C20H18N4 | 314.38 | | |
| 266 | 163978-50-5 | ETHYL 35DIFLUOROCINNAMATE | C11H10F2O2 | 212.19 | | |
| 267 | 163978-51-6 | 3-(3,5-DIFLUORO-PHENYL)-PROPIONIC ACID ETHYL ESTER | C11H12F2O2 | 214.21 | | |
| 268 | 1639787-05-5 | [2,2':5',2''-Terthiophene]-5-carboxaldehyde, 5''-bromo-3',3'',4-trihexyl- | C31H43BrOS3 | 607.77 | | |
| 269 | 163979-02-0 | H-ILE-NHNH2 | C6H15N3O | 145.2 | | |
| 270 | 163979-47-3 | 3-Methyl 5-((tetrahydrofuran-2-yl)methyl) 4-(2-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate | C21H24ClNO5 | 405.87 | | |
| 271 | 163979-48-4 | 3-Methyl 5-((tetrahydrofuran-2-yl)methyl) 4-(3-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate | C21H24ClNO5 | 405.87 | | |
| 272 | 163979-49-5 | 3-methyl 5-(tetrahydro-2-furanylmethyl) 4-(3-bromophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate | C21H24BrNO5 | 450.32296 | | |
| 273 | 1639791-77-7 | (4S,4'S)-2,2'-Cyclopentylidenebis[4,5-dihydro-4-phenylox azole] | C23H24N2O2 | 360.45 | | |
| 274 | 1639792-20-3 | Saroglitazar (Magnesium) | C50H56MgN2O8S2 | 901.43 | | |
| 275 | 1639793-13-7 | MC-Val-Cit-PAB-clindamycin | C46H72ClN8O11S+ | 980.64 | | |
| 276 | 1639793-15-9 | MC-Val-Cit-PAB-Retapamulin | C58H86N7O10S+ | 1073.42 | | |
| 277 | 1639795-23-5 | (trans-4-Ethynylcyclohexyl)methyl methanesulfonate | | | | |
| 278 | 1639798-42-7 | 19-(2-iodoethyl)heptatriacontane | C39H79I | 674.95 | | |
| 279 | 1639798-43-8 | 19-(4-iodobutyl)heptatriacontane | C41H83I | 703 | | |
| 280 | 16398-00-8 | 7-Chloro-5-phenyl-3H-1,4-benzodiazepine | C15H11ClN2 | 254.71 | | |
| 281 | 16398-07-5 | 2-CHLORO-N-(2-HYDROXYPHENYL)-5-NITROBENZAMIDE(WXG02102) | C13H9ClN2O4 | 292.67 | | |
| 282 | 16398-30-4 | 13-nitro-2-oxa-9-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,12,14-hexaene | C13H10N2O3 | 242.23 | | |
| 283 | 16398-39-3 | 10-[3-(dimethylamino)propyl]-2-nitrodibenz[b,f][1,4]oxazepin-11(10H)-one monohydrochloride | C18H20ClN3O4 | 377.8221 | 227-229 °C(Solv: ethanol (64-17-5); ethyl ether (60-29-7)) | |
| 284 | 163980-32-3 | Cyclohexanecarboxylic acid, 3-methylene-, ethyl ester | C10H16O2 | 168.23 | | |
| 285 | 163980-43-6 | Ethanone, 2-chloro-1-(2,5-dihydroxy-4-methoxyphenyl)- (9CI) | C9H9ClO4 | 216.62 | | |
| 286 | 1639803-39-6 | Benzoic acid, 5-methyl-2-(2-thiazolyl)- | C11H9NO2S | 219.26 | | |
| 287 | 1639809-02-1 | GDAT514 | | 854.11 | | |
| 288 | 1639809-46-3 | Maresin 2 | C22H32O4 | 360.49 | | |
| 289 | 1639810-41-5 | (E)-2-(2-((2-(hydroxymethyl)phenoxy)methyl)phenyl)-2-(methoxyimino)acetic acid | C17H17NO5 | 315.32 | 122 - 124°C | |
| 290 | 1639810-67-5 | Longiferone B | C15H22O | 218.33 | | |
| 291 | 1639810-83-5 | 2-(3-Bromophenyl)-5-phenylpyridine | C17H12BrN | 310.18788 | | |
| 292 | 1639820-81-7 | Pinatuzumab (anti-CD22) | | | | |
| 293 | 1639833-40-1 | Sofosbuvir Impurity 102 | C20H17FO6 | 372.35 | | |
| 294 | 1639836-65-9 | Deuterated Crosslinker DSP-d8 | C14H8D8N2O8S2 | 412.464734224 | | |
| 295 | 1639838-84-8 | 6,8-Dioxaspiro[3.5]nonane-2-carboxylic acid, 7-phenyl- | C14H16O4 | 248.2744 | | |
| 296 | 1639838-89-3 | 2-thiaspiro[3.3]heptan-6-amine hydrochloride | C6H12ClNS | 165.68 | | |
| 297 | 1639843-33-6 | DI-FMOC-SELENO-L-CYSTINE | C36H32N2O8Se2 | 778.57 | | |
| 298 | 1639843-35-8 | Fmoc-L-Sec(Xan)-OH | C31H25NO5Se | 570.49 | | |
| 299 | 1639843-37-0 | Fmoc-Sec(Trt)-OH | C37H31NO4Se | 632.61 | | |
| 300 | 1639843-65-4 | NH2-DOTA-GA | C21H38N6O9 | 518.57 | | |
| 301 | 1639847-49-6 | 1-bromo-3-chloro-5-ethynylbenzene | C8H4BrCl | 215.47 | | |
| 302 | 1639856-62-4 | (2E)-3-(2,5-dimethoxyphenyl)-1-(4-methoxyphenyl)prop-2-en-1-one | C18H18O4 | 298.33 | | |
| 303 | 1639856-65-7 | (2E)-1-(4-methoxyphenyl)-3-(2,3,4-trimethoxyphenyl)prop-2-en-1-one | C19H20O5 | 328.36 | | |
| 304 | 1639866-72-0 | 3-Amino-5-ethynylbenzoic acid | C9H7NO2 | 161.16 | | |
| 305 | 1639868-05-5 | 3-Morpholinone, 2-(2-hydroxypropyl)-2,5-dimethyl-4-(phenylmethyl)-, (5R)- | C16H23NO3 | 277.36 | | |
| 306 | 1639876-58-6 | 4-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)butan-1-aminium trifluoroacetate | C10H13F3N2O4 | 282.22 | | |
| 307 | 1639879-04-1 | 1-(2-Chloro-5-hydroxyphenyl)hydrazine hydrochloride | C6H8Cl2N2O | 195.04 | | |
| 308 | 1639881-08-5 | Pyrazolo[1,5-a]pyrazine, 4,5,6,7-tetrahydro-5-(phenylmethyl)- | C13H15N3 | 213.28 | | |
| 309 | 1639881-13-2 | tert-Butyl (6R)-6-methyl-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazine-5-carboxylate | C12H19N3O2 | 237.3 | | |
| 310 | 1639881-14-3 | tert-Butyl (6R)-3-bromo-6-methyl-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazine-5-carboxylate | C12H18BrN3O2 | 316.19 | | |
| 311 | 1639883-50-3 | 2-(((3aR,4S,6R,6aS)-6-((5-amino-6-chloro-2-(propylthio)pyrimidin-4-yl)amino)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol | C21H33ClN4O10S | 569.02 | | |
| 312 | 1639886-32-0 | BAY1217224 | C24H27ClFN3O5 | 491.94 | | |
| 313 | 1639886-51-3 | 6,6-dimethyl-3-Morpholinemethanol | C7H15NO2 | 145.2 | | |
| 314 | 1639886-52-4 | (2R,5R)-2,5-DiMethylMorpholine hydrochloride | C6H14ClNO | 151.63446 | | |
| 315 | 1639886-53-5 | Morpholine, 2,5-dimethyl-, hydrochloride, (2S,5R)- | C6H14ClNO | 151.63 | | |
| 316 | 1639891-84-1 | Imidazo[1,2-b]pyridazine-2-carboxylic acid, 6-chloro-8-(4-morpholinyl)-, ethyl ester | C13H15ClN4O3 | 310.74 | | |
| 317 | 1639891-85-2 | Imidazo[1,2-b]pyridazine-2-carboxylic acid, 8-(4-morpholinyl)-, ethyl ester | C13H16N4O3 | 276.29 | | |
| 318 | 1639891-86-3 | Imidazo[1,2-b]pyridazine-2-methanol, 8-(4-morpholinyl)- | C11H14N4O2 | 234.25 | | |
| 319 | 1639891-87-4 | Imidazo[1,2-b]pyridazine-2-carboxaldehyde, 8-(4-morpholinyl)- | C11H12N4O2 | 232.24 | | |
| 320 | 1639891-88-5 | tert-butyl 4-(2-formyl-8-morpholinoimidazo[1,2-b]pyridazin-3-yl)benzoate | | | | |
| 321 | 1639891-98-7 | Imidazo[1,2-b]pyridazine-2-methanol, 3-bromo-8-(4-morpholinyl)- | C11H13BrN4O2 | 313.15 | | |
| 322 | 1639891-99-8 | Imidazo[1,2-b]pyridazine-2-carboxaldehyde, 3-bromo-8-(4-morpholinyl)- | C11H11BrN4O2 | 311.13 | | |
| 323 | 1639892-05-9 | 4-(3-bromo-2-ethynylimidazo[1,2-b]pyridazin-8-yl)morpholine | | | | |
| 324 | 1639892-16-2 | ethyl 3-(6-chloropyridin-3-yl)-8-morpholinoimidazo[1,2-b]pyridazine-2-carboxylate | | | | |
| 325 | 1639892-17-3 | ethyl 3-(6-(4-(tert-butoxycarbonyl)piperazin-1-yl)pyridin-3-yl)-8-morpholinoimidazo[1,2-b]pyridazine-2-carboxylate | | | | |
| 326 | 1639892-18-4 | 3-(6-(4-(tert-butoxycarbonyl)piperazin-1-yl)pyridin-3-yl)-8-morpholinoimidazo[1,2-b]pyridazine-2-carboxylic acid | | | | |
| 327 | 1639892-20-8 | tert-butyl 4-(5-(2-(hydroxymethyl)-8-morpholinoimidazo[1,2-b]pyridazin-3-yl)pyridin-2-yl)piperazine-1-carboxylate | | | | |
| 328 | 1639892-32-2 | ethyl 2-(8-bromo-6-chloroimidazo[1,2-b]pyridazin-2-yl)acetate | | | | |
| 329 | 1639892-33-3 | ethyl 2-(6-chloro-8-morpholinoimidazo[1,2-b]pyridazin-2-yl)acetate | | | | |
| 330 | 1639892-60-6 | tert-butyl 4-(2-(hydroxymethyl)-8-morpholinoimidazo[1,2-b]pyridazin-3-yl)-5,6-dihydropyridine-1(2H)-carboxylate | | | | |
| 331 | 1639892-78-6 | Benzeneacetic acid, α-hydroxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, methyl ester | C15H21BO5 | 292.14 | | |
| 332 | 1639892-90-2 | 4-Piperidinecarboxylic acid, 1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-, ethyl ester | C20H30BNO4 | 359.27 | | |
| 333 | 1639895-85-4 | tBID | C11H3Br4N3O2 | 528.78 | | |
| 334 | 1639898-35-3 | Pyrazolo[1,5-a]pyrazin-4(5H)-one, 6,7-dihydro-7-methyl-3-(2-methyl-4-pyridinyl)-5-[4-(trifluoromethyl)phenyl]-, (7S)- | C20 H17 F3 N4 O | 386.37 | | |
| 335 | 16399-10-3 | 2-ETHYLAMINO-4-METHOXY-6-METHYL-1,3,5-TRIAZINE | C7H12N4O | 168.2 | | |
| 336 | 16399-46-5 | 2,4-Imidazolidinedione,3-[(2-chlorophenyl)methyl]-5-methyl- | C11H11ClN2O2 | 238.67024 | | |
| 337 | 16399-77-2 | FERROUS CHLORIDE DIHYDRATE | Cl2FeH4O2 | 162.78156 | | |
| 338 | 1639901-75-9 | Pyrazolo[1,5-a]pyrazin-4(5H)-one, 6,7-dihydro-3-iodo-7-methyl-, (7S)- | C7H8IN3O | 277.06 | | |
| 339 | 1639901-82-8 | Pyrazolo[1,5-a]pyrazin-4(5H)-one, 6,7-dihydro-3-iodo- | C6H6IN3O | 263.04 | | |
| 340 | 1639901-83-9 | Pyrazolo[1,5-a]pyrazin-4(5H)-one, 6,7-dihydro-7-methyl-3-(2-methyl-4-pyridinyl)-, (7S)- | C13H14N4O | 242.28 | | |
| 341 | 1639902-31-0 | methyl 4-bromo-1H-pyrazole-5-carboxylate | C5H5BrN2O2 | 205.0094 | | |
| 342 | 1639904-53-2 | N'-octylideneisonicotinohydrazide | C14H21N3O | 247.34 | | |
| 343 | 1639923-35-5 | 13H-Diindolo[2,3-a:3',2'-i]carbazole, 14,15-dihydro- | C24H15N3 | 345.4 | | |
| 344 | 1639924-58-5 | (2S,5R)-2,5-Dimethylmorpholine | C6H13NO | 115.17 | | |
| 345 | 1639925-34-0 | Flucopride | C22H33FN2O2 | 376.51 | | |
| 346 | 1639927-31-3 | Imidazo[1,2-c]pyrimidin-5(6H)-one, 8-iodo- | C6H4IN3O | 261.02 | | |
| 347 | 1639929-29-5 | 4H-1-Benzopyran-4-one, 2-(1H-1,2,4-triazol-1-yl)-3-[4-(trifluoromethyl)phenyl]- | C18H10F3N3O2 | 357.29 | | |
| 348 | 1639933-78-0 | LolCDE-IN-1 | C21H16FN3O | 345.37 | | |
| 349 | 1639933-79-1 | Pyridine, 4-[5-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-(1,1-dimethylethyl)-2H-imidazol-4-yl]- | C20H21N3O2 | 335.4 | | |
| 350 | 1639939-40-4 | Mc-Val-Ala-PAB-PNP | C32H37N5O10 | 651.66 | | |
| 351 | 1639939-56-2 | MC-VC-PAB-Tubulysin M | C66H93N11O15S | 1312.59 | | |
| 352 | 1639943-66-0 | R-4-fluoro-2'-(1-hydroxyethyl)biphenyl | | | | |
| 353 | 1639944-23-2 | benzyl trans-4-amino-3-hydroxy-3-methyl-piperidine-1-carboxylate | C14H20N2O3 | 264.32 | | |
| 354 | 1639945-15-5 | 1H-1,2,4-Triazole,1,1'-(9,9-dimethyl-9H-fluorene-2,7-diyl)bis- | C19H16N6 | 328.37 | | |
| 355 | 1639953-88-0 | Benzenesulfonamide, 4-methyl-N-[(9R,9aR)-2,3,9,9a-tetrahydro-7-methoxy-9a-(2-propen-1-yl)-1H-pyrrolo[1,2-a]indol-9-yl]-, rel- | C22H26N2O3S | 398.52 | | |
| 356 | 1639958-04-5 | Ethyl 2-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)acetate | C15H22BNO4 | 291.15 | | |
| 357 | 1639959-89-9 | D-Alanine, 3-[4,7,10-tris[2-(1,1-dimethylethoxy)-2-oxoethyl]-1,4,7,10-tetraazacyclododec-1-yl]-N-[2-[4,7,10-tris[2-(1,1-dimethylethoxy)-2-oxoethyl]-1,4,7,10-tetraazacyclododec-1-yl]acetyl]- (ACI) | | | | |
| 358 | 1639963-42-0 | (2-Azidoethoxy)methyl)tributylstannane | C15H33N3OSn | 390.16 | | |
| 359 | 1639963-79-3 | di-tert-butyl 2,5,8-triazaspiro[3.5]nonane-2,8-dicarboxylate | C16H29N3O4 | 327.41916 | | |
| 360 | 1639965-26-6 | MIND-4 | C24H17N5O3S | 455.49 | | |
| 361 | 1639965-60-8 | 7-fluoro-1H-imidazo[4,5-c]pyridin-4-amine | C6H5FN4 | 152.1291032 | | |
| 362 | 1639966-63-4 | L-Hercynine-d3 | C9H12D3N3O2 | 200.25 | | |
| 363 | 1639970-62-9 | (2R,4S)-4-([1,1'-Biphenyl]-4-ylmethyl)-2-methyl-4-(2,5-dioxopyrrolidin-1-yl)butanoic acid | C22H23NO4 | 365.42 | | |
| 364 | 1639972-90-9 | ANT-431 | C9H7N3O4S2 | 285.3 | | |
| 365 | 1639974-42-7 | Ethyl 5-bromo-2-(trifluoromethyl)thiazole-4-carboxylate | C7H5BrF3NO2S | 304.08 | | |
| 366 | 1639974-70-1 | 7-Chloro-5-hydroxy-imidazo[1,2-c]pyrimidine-2-carboxylic acid ethyl ester | C9H8ClN3O3 | 241.63 | | |
| 367 | 1639977-00-6 | Pyridine, 2-bromo-6-fluoro-3-nitro- | C5H2BrFN2O2 | 220.98 | | |
| 368 | 1639977-12-0 | 1H-Pyrrolo[2,3-c]pyridine, 7-bromo-5-fluoro- | C7H4BrFN2 | 215.02 | | |
| 369 | 1639977-64-2 | {5-fluoro-1-[tris(propan-2-yl)silyl]-1H-pyrrolo[2,3-c]pyridin-4-yl}boronic acid | C16H26BFN2O2Si | 336.28 | | |
| 370 | 1639978-21-4 | 2-chloro-6-bromo-3,4-diaminopyridine | C5H5BrClN3 | 222.47 | | |
| 371 | 1639986-05-2 | Benzenepentanoic acid, γ-amino-α-methyl-, ethyl ester, (αS,γR)- | C14H21NO2 | 235.33 | | |
| 372 | 1639993-98-8 | Doxycycline EP Impurity F | | | | |